sank after the company announced that it filed a shelf registration allowing it to sell $100 million of its stock.
The shares fell 8.8% to $4.78 Wednesday.
The registration statement carries forward $42 million in unissued shares under a previous registration statement from December 2005. The new registration statement has not yet become effective.
Novavax says it has no plans to access the capital markets right now.